Clinical Trial

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

Study acronym: OCES-2
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to investigate the relationship between body fat distribution measured by CT scan and related risk factors with the risk of incident metabolic and cardiovascular disease in a prospective cohort study of Japanese men and women. The investigators will also investigate novel risk factors for metabolic and cardiovascular disease using molecular weight-based metallomics analysis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-15.
Status change: Not Yet Recruiting → Recruiting 2024-11-29
Trial Details
NCT Number NCT06694012
Lead Sponsor Osaka Metropolitan University
Collaborators: The Ministry of Education, Culture, Sports, Science and Technology, Japan
Conditions Type 2 Diabetes Mellitus (T2DM), Type 2 Diabetes, Diabetes Mellitus, Hypertension, Hyperglycemia, Hyperlipidemia, Dyslipidemia, Hyperuricemia or Gout +11 more
Enrollment 2,000 participants
Start Date 2024-11-01
Primary Completion 2050-03-31 (estimated)
Study Completion 2050-03-31 (estimated)
Updated on ClinicalTrials.gov 2024-12-04